Health on MSN3d
What To Know About Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...
pharmaphorum4d
Conatus axes staff after latest failure of Novartis-partnered NASH drug
Driven by rising levels of obesity, NASH causes fibrosis and swelling in the liver and has become a leading concern in healthcare as increasing numbers of people with the condition advance to ...
PHILADELPHIA.Today on MSN12mon
Madrigal Pharmaceuticals First to Receive FDA Clearance for a NASH Treatment
Madrigal Pharmaceuticals has been given Food and Drug Administration market clearance for its experimental treatment for NASH ...